| |
| |
|
| Insider
Information: |
He Wei-Wu |
| Relationship: |
Chairman and CEO, Dire... |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
644,553 |
|
|
Indirect Shares
|
1,097,341 |
|
|
| Direct
Value |
$1,050,621 |
|
|
|
Indirect Value
|
$1,788,666 |
|
|
| Total
Shares |
1,741,894 |
|
|
| Total
Value |
$2,839,287 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
22
|
0
|
|
Stock
price went up :
|
10
|
0
|
| Stock
price went down : |
12
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -2.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Casi Pharmaceuticals Inc |
CASI |
Chairman and CEO, Dire... |
2022-06-15 |
644,553 |
2022-06-15 |
1,097,341 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2022-06-15 |
4 |
B |
$3.18 |
$159,000 |
D/D |
50,000 |
644,553 |
3.23 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2022-06-14 |
4 |
B |
$3.06 |
$6,414 |
D/D |
2,096 |
594,553 |
3.15 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2022-06-13 |
4 |
B |
$2.97 |
$107,092 |
D/D |
36,058 |
592,457 |
3.23 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2021-11-18 |
4 |
B |
$0.98 |
$196,000 |
D/D |
200,000 |
5,558,472 |
2.81 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2021-11-17 |
4 |
B |
$0.99 |
$198,000 |
D/D |
200,000 |
5,362,569 |
2.81 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2021-08-19 |
4 |
B |
$1.26 |
$226,800 |
D/D |
180,000 |
5,163,994 |
2.81 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2021-08-18 |
4 |
B |
$1.29 |
$387,000 |
D/D |
300,000 |
4,983,994 |
2.81 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2021-03-26 |
4 |
B |
$2.05 |
$6,150,000 |
I/I |
3,000,000 |
3,000,000 |
2.66 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2020-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
380,000 |
4,683,994 |
0 |
- |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2020-11-23 |
4 |
B |
$2.18 |
$218,000 |
D/D |
100,000 |
5,063,994 |
2.81 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2020-11-20 |
4 |
B |
$2.12 |
$270,239 |
D/D |
127,471 |
4,963,994 |
2.81 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-07-22 |
4 |
B |
$1.90 |
$2,280,000 |
I/I |
1,200,000 |
7,532,347 |
2.64 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-07-22 |
4 |
B |
$1.90 |
$5,609,609 |
D/D |
2,952,426 |
4,836,523 |
3.23 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-05-20 |
4 |
B |
$2.37 |
$133,820 |
D/D |
56,464 |
1,884,097 |
3.23 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-05-19 |
4 |
B |
$2.03 |
$60,496 |
D/D |
29,801 |
1,827,663 |
3.23 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-05-18 |
4 |
B |
$2.02 |
$684,643 |
D/D |
338,932 |
1,797,832 |
3.23 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-05-15 |
4 |
B |
$1.82 |
$182,000 |
D/D |
100,000 |
1,458,900 |
3.23 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2020-03-27 |
4 |
B |
$2.08 |
$14,310 |
D/D |
6,880 |
1,358,900 |
2.81 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-03-26 |
4 |
B |
$2.09 |
$685,719 |
D/D |
328,095 |
1,352,020 |
3.23 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-03-25 |
4 |
B |
$1.94 |
$381,012 |
D/D |
196,398 |
1,023,925 |
3.23 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-03-19 |
4 |
B |
$1.57 |
$368,146 |
I/I |
234,488 |
6,332,347 |
2.64 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-03-18 |
4 |
B |
$1.52 |
$762,009 |
I/I |
501,322 |
6,097,859 |
2.64 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2020-03-17 |
4 |
B |
$1.50 |
$396,288 |
I/I |
264,192 |
5,596,537 |
2.64 |
% |
|
| CASI |
Casi Pharmaceuticals Inc |
Chairman and CEO |
• • • |
2019-12-16 |
4 |
OE |
$1.69 |
$632,602 |
I/I |
374,321 |
5,332,345 |
0 |
- |
|
| CASI |
Casi Pharmaceuticals Inc |
Chief Executive Officer |
• • • |
2019-08-16 |
4 |
B |
$3.20 |
$64,000 |
D/D |
20,000 |
827,527 |
3.23 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
